Portfolio Lab

Aveanna Healthcare Holdings, Inc.

  • Stock
  • Ticker AVAH
  • Nasdaq

Health care · Health care services · USA

$11.01 +2.90%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Aveanna Healthcare Holdings, Inc. since 04/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

AVAHGlobal equities (VT)

$10,000 grew to $14,262. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −94.8% in 12/2022, measured from the peak in 06/2021. It took 62 months to get back to the old peak.

1-year return
+32.7%
5-year return p.a.
+8.3%
Return p.a. since 04/2021
−1.5%
Volatility p.a.
89.8%
Largest decline
−94.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202501/202604/202607/202610/2026
Income statement
Revenue520559590622662648670696
Gross profit172184211203213205219227
Operating income4652805471698084
EBITDA4854835674728387
Net income295.22714179424045
Earnings per share0.150.030.130.060.830.190.180.20
Balance sheet
Total assets1,6631,6611,7711,8102,0122,0222,1062,207
Liabilities1,7851,7591,7821,8011,8171,7811,8181,868
Equity-124-100-129.2194240287337
Cash847110114619318997198
Long-term debt1,2721,2711,2691,2891,2871,2841,2851,282
Cash flow
Operating cash flow13-8.65233504.38172
Free cash flow13-8.65233504.38172

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +243.6%, weakest 2022 at −89.5%. 3 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
12 Nov 2026$0.20
13 Aug 2026$0.18
14 May 2026$0.19
19 Mar 2026$0.83
6 Nov 2025$0.06
7 Aug 2025$0.13
8 May 2025$0.03
13 Mar 2025$0.15
7 Nov 2024−$0.22
8 Aug 2024$0.07
9 May 2024−$0.06
14 Mar 2024−$0.14

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.2bn
Market cap in trading currency
$2.40bn
Enterprise value
$3.50bn
P/E
7.9
P/S
0.90
P/B
7.13
EV/Sales
1.31
EV/EBITDA
11.1
Earnings yield
12.7%
FCF yield
8.6%

Results (last four quarters)

Revenue
$2.68bn
Gross profit
$864m
EBITDA
$316m
Net income
$306m
Earnings per share
$1.40
Revenue per share
$12.25
Revenue growth
+11.8%
Earnings growth
+223.2%

Profitability

Gross margin
32.3%
Operating margin
11.4%
Net margin
11.4%
Return on equity
176.7%
Return on assets
13.9%

Balance sheet and cash flow

Cash
$198m
Cash per share
$0.91
Financial debt
$1.30bn
Debt/equity %
384
Current ratio
1.23
Book value per share
$1.54
Operating cash flow
$207m
Free cash flow
$207m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
218m
Volume
2.16m
Avg. volume 3 months
2.92m
Relative volume
0.8

Price and technicals

Price
$11.01
1 day
+2.9%
52-week high
$14.38
52-week low
$6.22
Distance to 52-week high
−23.4%
Distance to 52-week low
+77.0%
Distance to 50-day line
−13.7%
Distance to 200-day line
+15.7%
RSI (14)
33
Volatility 1M
54.1%

Performance

1 week
−4.3%
1 month
−17.3%
3 months
−19.6%
6 months
+50.2%
YTD
+34.8%
1 year
+30.3%

Dates

Fiscal year end
3 Jan 2026
Most recent quarter
3 Oct 2026

Frequently asked questions

How has AVAH performed since 04/2021?

$10,000 grew to $9,175 by 20 Nov 2026, which is −1.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is AVAH?

Volatility was 89.8% per year, measured on monthly returns. The largest decline from a peak was −94.8%, with the low in 12/2022.

How does AVAH compare with a broad equity ETF?

Over the same period Global equities (VT) returned +8.2% per year at 14.9% volatility, AVAH returned −1.5% at 89.8%. The correlation of monthly returns was 0.38; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Aveanna Healthcare Holdings, Inc. (AVAH): Return and risk